Tissue Differentiation Intelligence

Tissue Differentiation Intelligence is a private U.S. medical device company focused on AI-enabled, real-time surgical ultrasound imaging for spine procedures. Its lead product platform, SonoVision, is designed to help surgeons visualize and differentiate nerves, vasculature, bone, muscle, and related anatomical structures during intraoperative access to the spine. The company received FDA 510(k) clearance in 2020 for the SonoVision Ultrasound Imaging System, supporting commercial use of the platform in spine surgery. TDi appears to operate as a small, specialized healthcare technology company combining ultrasound hardware, image-processing algorithms, and machine learning for procedure-enabling surgical imaging.